Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 3
2016 17
2017 20
2018 46
2019 22
2020 2
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 29986988

100 results
Results by year
Filters applied: . Clear all
Page 1
New Immunotherapies in Oncology Treatment and Their Side Effect Profiles.
Sriratana P, Norton J. Sriratana P, et al. J Am Board Fam Med. 2018 Jul-Aug;31(4):620-627. doi: 10.3122/jabfm.2018.04.170387. J Am Board Fam Med. 2018. PMID: 29986988 Free article. Review.
Combination Immunotherapy with CAR T Cells and Checkpoint Blockade for the Treatment of Solid Tumors.
Grosser R, Cherkassky L, Chintala N, Adusumilli PS. Grosser R, et al. Cancer Cell. 2019 Nov 11;36(5):471-482. doi: 10.1016/j.ccell.2019.09.006. Cancer Cell. 2019. PMID: 31715131 Review.
Current developments in immunotherapy in the treatment of multiple myeloma.
Köhler M, Greil C, Hudecek M, Lonial S, Raje N, Wäsch R, Engelhardt M. Köhler M, et al. Cancer. 2018 May 15;124(10):2075-2085. doi: 10.1002/cncr.31243. Epub 2018 Feb 6. Cancer. 2018. PMID: 29409124 Free article. Review.
Immunotherapy: enhancing the efficacy of this promising therapeutic in multiple cancers.
Inthagard J, Edwards J, Roseweir AK. Inthagard J, et al. Clin Sci (Lond). 2019 Jan 18;133(2):181-193. doi: 10.1042/CS20181003. Print 2019 Jan 31. Clin Sci (Lond). 2019. PMID: 30659159 Review.
Immunogenicity of immunomodulatory, antibody-based, oncology therapeutics.
Davda J, Declerck P, Hu-Lieskovan S, Hickling TP, Jacobs IA, Chou J, Salek-Ardakani S, Kraynov E. Davda J, et al. J Immunother Cancer. 2019 Apr 15;7(1):105. doi: 10.1186/s40425-019-0586-0. J Immunother Cancer. 2019. PMID: 30992085 Free PMC article. Review.
New NCCN Guidelines: Recognition and Management of Immunotherapy-Related Toxicity.
Thompson JA. Thompson JA. J Natl Compr Canc Netw. 2018 May;16(5S):594-596. doi: 10.6004/jnccn.2018.0047. J Natl Compr Canc Netw. 2018. PMID: 29784734
Immunotherapy for the Treatment of Hodgkin Lymphoma: An Evolving Paradigm.
Bair SM, Mato A, Svoboda J. Bair SM, et al. Clin Lymphoma Myeloma Leuk. 2018 Jun;18(6):380-391. doi: 10.1016/j.clml.2018.03.012. Epub 2018 Mar 31. Clin Lymphoma Myeloma Leuk. 2018. PMID: 29685424 Review.
Inflammatory and Infectious Syndromes Associated With Cancer Immunotherapies.
Fishman JA, Hogan JI, Maus MV. Fishman JA, et al. Clin Infect Dis. 2019 Aug 30;69(6):909-920. doi: 10.1093/cid/ciy1025. Clin Infect Dis. 2019. PMID: 30520987 Review.
Endocrine dysfunction induced by immune checkpoint inhibitors: Practical recommendations for diagnosis and clinical management.
Barroso-Sousa R, Ott PA, Hodi FS, Kaiser UB, Tolaney SM, Min L. Barroso-Sousa R, et al. Cancer. 2018 Mar 15;124(6):1111-1121. doi: 10.1002/cncr.31200. Epub 2018 Jan 3. Cancer. 2018. PMID: 29313945 Free article. Review.
Chimeric Antigen Receptor T Cell Therapy in Hematology.
Ataca P, Arslan Ö. Ataca P, et al. Turk J Haematol. 2015 Dec;32(4):285-94. doi: 10.4274/tjh.2015.0049. Epub 2015 Aug 6. Turk J Haematol. 2015. PMID: 26377367 Free PMC article. Review.
100 results
Jump to page
Feedback